Federal contract award

15B20525P00000030

NATIONAL DRUG CODE: 66215-0602-06 GENERIC NAME: SELEXIPAG 200MCG TAB TRADE NAME: UPTRAVI 200MCG TAB VA CLASS: CARDIOVASCULAR AGENTS,OTHER

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Justice
OfficeFMC DEVENS
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$29.2K
Current contract value$29.2K
Potential contract value / ceiling$29.2K
Start dateFeb 4, 2025
Current end dateFeb 6, 2025
Potential end dateFeb 6, 2025
Latest award activityFeb 4, 2025
Source loadedAug 15, 2026

Funding and modification history

Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Feb 4, 20250$29.2KNATIONAL DRUG CODE: 66215-0602-06 GENERIC NAME: SELEXIPAG 200MCG TAB TRADE NAME: UPTRAVI 200MCG TAB VA CLASS: CARDIOVASCULAR AGENTS,OTHER

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Charles CoushaineContactccoushaine@bop.gov
9787961136
SourceJan 31, 2025
Eve Rivera-WhiteContacteriverawhite@bop.gov
9787961146
SourceJan 31, 2025

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.